Jun Li^1*, Yanqing Huang^1*, Yue Hou^1*, Jie Zi^1*, Chunhua Song, MD，PhD^2,3 and Zheng Ge, MD, PhD¹

¹Department of Hematology, Zhongda Hospital, School of Medicine, Institute of Hematology, Southeast University, Nanjing, China
²Hershey Medical Center, Pennsylvania State University Medical College, Hershey
³Division of Hematology, The Ohio State University Wexner Medical Center, the James Cancer Hospital, Columbus

Jonathan A. Gutman, MD¹, Amanda C. Winters, MD, PhD², Andrew Kent, MD, PhD^3*, Maria L. Amaya, MD, PhD⁴, Christine M. McMahon, MD⁴, Clayton Smith, MD^5*, Craig T Jordan, PhD⁶, Brett M. Stevens, PhD⁴, Mohammad Minhajuddin, PhD^4*, Shanshan Pei, PhD^7*, Jeffrey Schowinsky, MD^6*, Jennifer Tobin, PharmD^8*, Kelly O'Brien, NP^5*, Angela Falco, NP^9*, Elizabeth Taylor, RN^9*, Constance Brecl, BA, CCRP, RAC^9*, Phuong Ho, BS^10*, Connor Sohalski, BS^9*, Jessica Dell-Martin, BS^9*, Olivia Ondracek, BS^11*, Diana Abbott, PhD^12* and Daniel A. Pollyea, MD¹³

¹Division of Hematology, Department of Medicine, University of Colorado, Aurora, CO
²University of Colorado Anschutz Medical Campus, Aurora, CO
³Department of Medicine, University of Colorado Hospital, Denver, CO
⁴Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Aurora, CO
⁵Division of Hematology, University of Colorado, Aurora, CO
⁶University of Colorado, Aurora, CO
⁷University of Colorado, Anschutz Medical Campus, Aurora, CO
⁸University of Colorado Cancer Center, Aurora, CO
⁹Division of Hematology, University of Colorado, Aurora
¹⁰University of Colorado, Aurora
¹¹Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical School, Aurora, CO
¹²Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Denver, CO
¹³Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Denver, CO

Farhad Ravandi, MD¹, Pau Montesinos, MD, PhD^2*, Michael Pfeilstöcker, MD^3*, Cristina Papayannidis, MD, PhD⁴, Hervé Dombret, MD, PhD^5,6, Yinzhi Lai, PhD^7*, Erica Petrlik, MD, MPH^7*, Thomas Prebet, MD, PhD^7* and Hartmut Döhner, MD⁸

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Hospital Universitario y Politécnico La Fe, Valencia, Spain
³Hanusch Hospital, Vienna, Austria
⁴IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
⁵Institut de Recherche Saint Louis, Université de Paris, Paris, France
⁶Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris (AP-HP), Paris, France
⁷Bristol Myers Squibb, Princeton, NJ
⁸Ulm University Hospital, Ulm, Germany

Tara L. Lin, MD¹, Praneeth Baratam^2*, Robert K. Stuart^2*, Roland B. Walter, MD, PhD, MS³, Eric S. Winer, MD⁴, Stefan Faderl^5*, Vijayalakshmi Chandrasekaran^6*, Divya Chakravarthy^5*, Ronald S. Cheung⁵ and Vinod A. Pullarkat, MD^7*

¹University of Kansas Medical Center, Kansas City, KS
²Medical University of South Carolina, Charleston, SC
³Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Jazz Pharmaceuticals, Palo Alto, CA
⁶Jazz Pharmaceuticals, Philadelphia, PA
⁷Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA

Amer M. Zeidan, MD¹, Wei-Han Cheng, PhD^2*, Rajesh Kamalakar, MS^2*, Catherine Miller, PharmD^2*, Cat N. Bui, PharmD^2*, Melissa Montez, PharmD^3*, Tracy Yee, PhD, MPH^4*, Zheng Wu, MS^4* and Scott F. Huntington, MD, MPH¹

¹Yale School of Medicine, Smilow Cancer Hospital at Yale New Haven, New Haven, CT
²AbbVie, Inc, Health Economics and Outcomes Research - Oncology, Chicago, IL
³Genentech, Inc, Health Economics and Outcomes Research - Oncology, San Francisco, CA
⁴Genesis Research, LLC, Hoboken, NJ

Amir T. Fathi, MD¹, Geoffrey G Fell^2*, Areej El-Jawahri, MD^3,4*, Alexander E. Perl, MD⁵, Brian A. Jonas, MD, PhD⁶, Ajoy L. Dias, MD⁷, Alice S. Mims, MD⁸, Uma Borate, MD⁹, Brittany Knick Ragon, MD¹⁰, Michael R. Grunwald, MD¹¹, Mary Linton B. Peters, MD^12*, Timothy A. Graubert, MD¹³, Philip C. Amrein, MD¹⁴, Hanno R. Hock, MD, PhD^15*, Andrew M. Brunner, MD¹⁶, Gabriela S. Hobbs, MD¹⁷, Rupa Narayan, MD¹⁸, Donna S. Neuberg, ScD² and Ibrahim Aldoss, MD¹⁹

¹Massachusetts General Hospital, Harvard Medical School, Boston, MA
²Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
³Massachusetts General Hospital/Harvard Medical School, Boston, MA
⁴Blood and Marrow Transplant Program, Massachusetts General Hospital, Allston, MA
⁵University of Pennsylvania, Philadelphia, PA
⁶Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
⁷Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
⁸Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁹Division of Hematology, The Ohio State University, Columbus, OH
¹⁰Levine Cancer Institute, Atrium Health, Charlotte, NC
¹¹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
¹²Beth Israel Deaconess Medical Center, Boston, MA
¹³Massachusetts General Hospital Cancer Center, Charlestown, MA
¹⁴Leukemia Center/MGH Cancer Center, Massachusetts General Hospital, Belmont, MA
¹⁵Leukemia Center, Massachusetts General Hospital / Harvard Medical School, Boston, MA
¹⁶Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
¹⁷Cancer Center, Massachusetts General Hospital, Boston, MA
¹⁸Massachusetts General Hospital Cancer Center, Boston, MA
¹⁹City of Hope, Duarte, CA

Man Wai Tang, PhD¹, Deborah van der Tuin^1*, Mesire Aydin^1*, Jarom Heijmans, MD, PhD^1*, Arjan A. van de Loosdrecht, MD, PhD^2*, Ellen Meijer, MD, PhD¹, Caroline E. Rutten, MD, PhD^1*, Marielle Wondergem, MD, PhD¹, Jeroen J.W.M. Janssen, MD, PhD^1*, Marjolein Donker, MD, PhD^1*, Mette D. Hazenberg, MD, PhD^3*, Sonja Zweegman, MD, PhD⁴, Bart J Biemond⁵, David C. de Leeuw, MD, PhD^1* and Erfan Nur, MD, PhD¹

¹Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands
²Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands
³Department of Hematology, Amsterdam UMC Cancer Center Amsterdam, Amsterdam, Netherlands
⁴Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands
⁵Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands

Toshiki Terao, MD^*, Ken-ichi Matsuoka, MD, PhD, Hiroko Ueda, MD^*, Akifumi Matsumura, MD^*, Chisato Matsubara, MD^*, Kaho Kondo, MD^*, Takumi Kondo, MD, PhD^*, Hideaki Fujiwara, MD, PhD, Noboru Asada, MD, PhD, Daisuke Ennishi, MD, PhD, Hisakazu Nishimori, MD, PhD^*, Keiko Fujii, MD, PhD^*, Nobuharu Fujii, MD, PhD^* and Yoshinobu Maeda, MD, PhD

Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan

Jie Zha, MD, PhD^1*, Hui Zhou^1*, Mengya Zhong, MD, PhD^1,2*, Ying Wang, MD³, Xin Du^4*, Tiejun Gong^5*, Zhijuan Lin, MD^6*, Yun Cai^7*, Siting Xie^6*, Chendi Xie^6*, XianQi Feng^8*, ZhenQi Huang^9*, Liping Su^10*, Jianmin Luo^11*, Lin Yang^12*, Zhenling Li^13*, Bi-yun Chen, MD, PhD^14*, Ying Xie^15*, Yu Zhu, MD, PhD^16*, Pengcheng Shi^17*, Zhifeng Li^18*, Yirong Jiang^19* and Bing Xu, MD, PhD^20*

¹Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
²Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, xiamen, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴Department of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, CA, China
⁵Harbin Institute of Hematology and Oncology, Harbin First Hospital，150010 Harbin,Heilongjiang,China, Harbin, China
⁶Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, xiamen, China
⁷Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, shenzhen, China
⁸Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
⁹The First Affiliated Hospital of Anhui Medical University, Hefei, China
¹⁰Department of Hematology, Shanxi Cancer Hospital, Taiyuan, China
¹¹The Second Hospital of Hebei Medical University, Shijiazhuang, China
¹²Department of Hematology, Second Hospital of Hebei Medical University, Shijiazhuang, CHN
¹³Department of Hematology, China-Japan Friendship Hospital, Beijing, China
¹⁴Department of Hematology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China
¹⁵Department of Hematology, Fujian Provincial Hospital, Fuzhou, China
¹⁶Department of Hematology, Collaborative Innovation Center for Cancer Personalized Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Provincial People’s Hospital, Nanjing, China
¹⁷Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
¹⁸Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, China
¹⁹Department of Hematology, Dongguan People’s Hospital, Dongguan, China
²⁰Department of Hematology, The first Affiliated Hosptial of Xiamen University, Xiamen, China

Vishesh Khanna, MD¹, Tali Azenkot, MD^2*, Selina (Qiuying) Liu, MD³, Jason Gilbert, MD^4*, Edna Cheung, PharmD^5*, Kimberly Lau, PharmD^5*, Daniel A. Pollyea, MD⁴, Elie Traer, MD, PhD³, Brian A. Jonas, MD, PhD⁶, Tian Y. Zhang⁵ and Gabriel N. Mannis, MD⁷

¹Division of Hematology, Department of Medicine, Stanford University Medical Center, Palo Alto, CA
²Department of Internal Medicine, University of California Davis School of Medicine, Sacramento
³Knight Cancer Institute, Division of Hematology & Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR
⁴Division of Hematology, University of Colorado School of Medicine, Aurora, CO
⁵Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA
⁶Division of Cellular Therapy, Bone Marrow Transplant, and Malignant Hematology, Department of Medicine, University of California Davis School of Medicine, Sacramento, CA
⁷Division of Hematology, Department of Medicine, Stanford University Medical Center, Menlo Park, CA

Hannah Otiker, PharmD^1*, Gustavo Rivero, MD², Ashley Sidebottom^1* and Grace Hwang, PharmD^1*

¹Department of Pharmacy, Baylor St.Luke's Medical Center, Houston, TX
²Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX

Xiaohong Liu^1*, Yao Li^1*, Wenjing Yu, MD^1*, Xiaolu Zhu^1*, Jinsong Jia^1*, Lizhong Gong^1*, Xiaosu Zhao^1*, Yingjun Chang^1*, Xiao-Jun Huang¹ and Hao Jiang^2*

¹Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
²Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China

Sai Prasad Desikan, MD^1*, Hagop Kantarjian, MD², Elias Jabbour, MD¹, Kelly S. Chien, MD¹, Guillermo Montalban-Bravo, MD¹, Yesid Alvarado, MD¹, Gautam Borthakur, MD¹, Ghayas C. Issa, MD³, Naval Daver, MD¹, Naveen Pemmaraju, MD¹, Musa Yilmaz, MD⁴, Danielle Hammond, MD¹, Abhishek Maiti, MBBS⁵, Courtney D. DiNardo, MD, MSCE¹, Farhad Ravandi, MD¹, Guillermo Garcia-Manero, MD⁶ and Tapan M. Kadia, MD⁴

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX
⁶Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Andree-Anne Pelland, MD, Xavier Savard, MD^*, Frederic Barabe, MD, Vincent Laroche, MD, Michaël Munger, MD^*, Genevieve Gallagher, MD, Nicolas Marcoux, MD, Guy Cantin, MD^*, Maxime Chénard-Poirier, MD^*, Robert Delage, MD, Marc Lalancette, MD and Christopher Lemieux, MD

Centre intégré de cancérologie, CHU de Québec - Université Laval, Quebec, QC, Canada

Ellen Madarang, PharmD^1*, Jillian Lykon, PharmD^1*, Wei Zhao, MD, MS^2*, Mikkael A. Sekeres, MD¹, Terrence Bradley, MD¹, Namrata Sonia Chandhok, MD¹, Justin Taylor, MD¹, Tulay Koru-Sengul, PhD^3*, Sunil G. Iyer, MD^1*, Jacopo Nanni, MD^4*, Cristina Papayannidis, MD, PhD⁵, Ryan M Miller, PhamD^6*, Ashwin Kishtagari, MBBS⁷, Michael R. Savona, MD⁸, Jason Gilbert, MD^9*, Daniel A. Pollyea, MD¹⁰, David A. Sallman, MD¹¹, Najla Al Ali, MS¹¹, Rami S. Komrokji, MD¹² and Justin Watts, MD¹

¹University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
²Division of Biostatistics, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
³Division of Biostatistics, Department of Public Health Sciences, University of Miami, Miami, FL
⁴Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
⁵IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy, Bologna, Italy
⁶Vanderbilt Ingram Cancer Center, Nashville, TN
⁷Division of Hematology & Oncology, Vanderbilt Ingram Cancer Center, Franklin, TN
⁸Vanderbilt University School of Medicine, Nashville, TN
⁹Division of Hematology, University of Colorado School of Medicine, Aurora, CO
¹⁰Anschutz Medical Campus, Division of Hematology, University of Colorado School of Medicine, Denver, CO
¹¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
¹²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Philip C. Amrein, MD^1,2, Eyal C. Attar, MD³, Geoffrey G Fell^4*, Traci M. Blonquist, MS^5*, Andrew M. Brunner, MD^6,7, Gabriela S. Hobbs, MD⁸, Hanno R. Hock, MD, PhD^9*, Steven McAfee^2*, Rupa Narayan, MD^10,11, Jenna A. Moran, NP^8*, Meghan Bergeron, NP^10*, Julia E. Foster, NP^10*, Christina Bertoli, NP^2,10*, Kristin McGregor^10*, Meghan Burke^10*, Tanya T. Behnan, BS^10*, Tina T. Som, RN^10*, Aura Y. Ramos, RN^10*, Megan K. Vartanian, RN^10*, Jennifer Lombardi Story^10,12*, Donna S. Neuberg, ScD⁴ and Amir T. Fathi, MD^11,13

¹Leukemia Center/MGH Cancer Center, Massachusetts General Hospital, Belmont, MA
²Massachusetts General Hospital, Boston, MA
³Aprea Therapeutics, Boston, MA
⁴Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁵Data Science, Dana-Farber Cancer Institute, Boston, MA
⁶Mass General Cancer Center, Massachusetts General Hospital, Boston, MA
⁷Dana-Farber Cancer Institute, Boston, MA
⁸Cancer Center, Massachusetts General Hospital, Boston, MA
⁹Leukemia Center, Massachusetts General Hospital / Harvard Medical School, Boston, MA
¹⁰Leukemia Center, Massachusetts General Hospital, Boston, MA
¹¹Massachusetts General Hospital Cancer Center, Boston, MA
¹²Leukemia Program, Massachusetts General Hospital, Boston, MA
¹³Center for Leukemia, Massachusetts General Hospital / Harvard Medical School, Cambridge, MA

James McCloskey, MD^1*, Vinod A. Pullarkat, MD^2*, Gabriel N. Mannis, MD³, Tara L. Lin, MD⁴, Stephen A Strickland, MD, MSCI⁵, Amir T. Fathi, MD⁶, Stefan Faderl^7*, Divya Chakravarthy^7*, Yana Lutska^8*, Vijayalakshmi Chandrasekaran^8*, Ronald S. Cheung⁷ and Mark J. Levis, MD⁹

¹John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
³Stanford University Medical Center, Palo Alto, CA
⁴University of Kansas Medical Center, Kansas City, KS
⁵Vanderbilt-Ingram Cancer Center, Nashville, TN
⁶Massachusetts General Hospital, Harvard Medical School, Boston, MA
⁷Jazz Pharmaceuticals, Palo Alto, CA
⁸Jazz Pharmaceuticals, Philadelphia, PA
⁹Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

Rabia Shahswar, MD^1*, Gernot Beutel, MD^1*, Razif Gabdoulline, PhD^1*, Adrian Schwarzer, MD, PhD¹, Arnold Kloos, PhD^1*, Christian Koenecke, MD^1*, Michael Stadler, MD^1*, Gudrun Göhring, MD^2*, Brigitte Schlegelberger, MD², Zhixiong Li, MD¹, Louisa-Kristin Dallmann^1*, Clara Wienecke^1*, Piroska Klement, MD^1*, Catherin Albert^1*, Martin Wichmann^1*, Yasmine Alwie^1*, Axel Benner^3*, Maral Saadati, PhD^4*, Arnold Ganser, MD^5*, Felicitas R. Thol, MD¹ and Michael Heuser, MD¹

¹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
²Department of Human Genetics, Hannover Medical School, Hannover, Germany
³Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany
⁴Saadati Solutions, Ladenburg, Germany
⁵Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany

Julia M. Unglaub, MD^1*, Richard F. Schlenk, MD^2,3, Maher Hanoun, MD, PhD^4*, H. Christian Reinhardt, MD^5*, Jan Moritz Middeke, MD^6*, Kerstin Schäfer-Eckart^7*, Björn Steffen, MD^8*, Stefan W. Krause, MD^9*, Christoph Schliemann, MD^10*, Martin Kaufmann, MD¹¹, Mathias Haenel, MD^12*, Edgar Jost^13*, Martina Crysandt, MD^13*, Lars Fransecky, MD^14*, Hermann Einsele, MD¹⁵, Sabrina Kraus^16*, Dirk Niemann, MD^17*, Andreas Neubauer, MD¹⁸, Ruth Seggewiss-Bernhardt, MD^19*, Sebastian Scholl, MD^20*, Stefan Klein, MD²¹, Christoph Schmid, MD^22*, Markus Schaich, MD^23*, Uwe Platzbecker, MD^24*, Claudia D. Baldus, MD^25*, Martin Bornhaeuser, MD²⁶, Hubert Serve, MD²⁷, Christoph Röllig, MD, MSc^28*, Michael Kramer, MSc^26*, Elena Katelari^29*, Maike Janssen, MD^3*, Caroline Pabst, MD^30*, Thomas Luft, MD, PhD³¹, Peter Dreger, MD³², Carsten Müller-Tidow, MD^33* and Tim Sauer, MD^34*

¹University Hospital Heidelberg, Heidelberg, Germany
²National Center of Tumor Diseases, Heidelberg, Heidelberg, Germany
³Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
⁴Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁵Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁶Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
⁷Department of Internal Medicine 5, Hospital Nürnberg, Nürnberg, Germany
⁸Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Goethe-University, Frankfurt, Germany
⁹Department of Hematology and Medical Oncology, University Hospital Erlangen, Erlangen, Germany
¹⁰Department of Medicine A, University Hospital Münster, Münster, Germany
¹¹2nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital, Stuttgart, Germany
¹²Department of Internal Medicine III, Chemnitz Hospital, Chemnitz, Germany
¹³Department of Internal Medicine IV, University Hospital RWTH Aachen, Aachen, Germany
¹⁴Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
¹⁵Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
¹⁶University Hospital of Wurzburg, Wurzburg, DEU
¹⁷Department of Hematology/Oncology and Palliative Medicine, Ev. Stift St. Martin, Koblenz, Germany
¹⁸Hematology, Oncology, Immunology, Philipps University, Marburg, Germany
¹⁹Department of Hematology/Oncology, Sozial-Stiftung Bamberg, Bamberg, Germany
²⁰Department of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany
²¹Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany
²²Department of Haematology and Oncology, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
²³Department of Hematology, Oncology and Palliative Care, Rems-Murr-Klinikum Winnenden, Germany, Winnenden, Germany
²⁴Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
²⁵Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany
²⁶Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
²⁷Department of Medicine II, Hematology and Oncology, University Hospital Frankfurt, Frankfurt, Germany
²⁸Department of Internal Medicine I, University Hospital, Dresden, Germany
²⁹Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
³⁰Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
³¹Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
³²Internal Medicine V - Hematology, Oncology & Rheumatology, University of Heidelberg, Heidelberg, Germany
³³Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany
³⁴Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Baden-Württemberg, Germany

Gina Keiffer, MD¹, Guneet Kaleka^2*, Caspian Oliai, MD, MS³, Lindsay Wilde, MD¹, Neil Palmisiano, MD, MS⁴ and Margaret Kasner, MD¹

¹Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
²Department of Medicine, UCLA-Olive View Medical Center, Newbury Park, CA
³UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
⁴Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA